Randi Seigel was quoted in an article by Modern Healthcare about how Trump could impact telehealth companies providing abortion care and medication.
Manatt Health Managing Director Alex Morin will speak at Baker Institute’s “Health Care at Risk: Texas Abortion Laws and OB-GYN Access,” event on Thursday, October 10, 2024 from 7:30 – 9:00 am CST. This event will take...
Below is an excerpt from a recent study conducted by Manatt Health to analyze the Texas OB/GYN physician workforce and the impact of the state’s abortion laws on the workforce development pipeline.
With the notable exception of reproductive health, the candidates’ focus on immigration, inflation and differences in style and vision for the future have sidelined detailed discussions of health care policy during the 2024 campaign.
For states, managed care organizations, and providers—who all play a vital role in ensuring access to family planning services and supplies for the nearly 20 million women ages 18-44 enrolled in Medicaid—the CIB reiterates existing...
Manatt Health Partners Rachel Sher and Julian Polaris discussed the U.S. Supreme Court’s decision in Alliance for Hippocratic Medicine (AHM) v. U.S. Food and Drug Administration (FDA), including its significance for access to medication...
On April 22, the Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR) released a Final Rule to enhance the privacy of information related to reproductive health care.
Helen Pfister and Julian Polaris discussed how states can help ensure that Medicaid and CHIP covered pregnant women have proper access to vaccines.
Rachel Sher was quoted in a Law360 article on how the Supreme Court cases surrounding mifepristone could impact FDA’s drug approval and regulatory authority.
On December 15, 2023, the CMS Innovation Center (CMMI) announced a new voluntary model for state Medicaid agencies called Transforming Maternal Health (TMaH).